Stay updated with breaking news from Regarding Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FREMONT, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported financial results for the second quarter ended June 30, 2023.
For the three-month period ended June 30, 2022 For the three-month period ended June 30, 2023$ in thousands Plants TherapeuticsTotal reportable segments Plants TherapeuticsTotal reportable...
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the second quarter ended June 30, 2023. Key highl...
Revenues increased 16 percent sequentially to $123.2 million; GAAP earnings were $0.26 per diluted share; non-GAAP earnings were $0.36 per diluted share ...
27.07.2023 - DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2023. Second Quarter 2023 Financial Highlights: Revenue grew 25% versus the same quarter of the prior year to $871.3 million on a reported ...